TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Spago Nanomedical AB (publ)
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Turnover |
1,219
|
997
|
644 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-42,773
|
-37,077
|
-38,103 |
EBITDA |
-43,350
|
-36,994
|
-37,854 |
Total assets |
53,675
|
194,814
|
186,876 |
Current assets |
52,583
|
61,714
|
53,039 |
Current liabilities |
11,627
|
8,321
|
6,643 |
Equity capital |
41,855
|
186,492
|
180,233 |
- share capital |
19,105
|
86,025
|
40,162 |
Employees (average) |
13
|
15
|
16 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Solvency |
78.0%
|
95.7%
|
96.4% |
Turnover per employee |
94
|
66
|
40 |
Profit as a percentage of turnover |
-3508.9%
|
-3718.9%
|
-5916.6% |
Return on assets (ROA) |
-79.7%
|
-19.0%
|
-20.4% |
Current ratio |
452.2%
|
741.7%
|
798.4% |
Return on equity (ROE) |
-102.2%
|
-19.9%
|
-21.1% |
Change turnover | |||
Change turnover % |
60%
|
93% | |
Chg. No. of employees | |||
Chg. No. of employees % |
-6%
|
7% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.